Zenas Biopharma Inc (ZBIO)

Cost of Revenue

$60.73M

TTM · Period ending: · USD

ZBIO logo

ZBIO Cost of Revenue

Latest reported$60.73M
ZBIO TTM Cost of Revenue ($31.32M → $60.73M)
High-resolution chart · PNG

ZBIO cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Zenas Biopharma Inc Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
60,726,000
103,753,000
103,747,000
48,027,000
76,557,000
67,337,000
89,982,000
110,400,000
76,870,000
43,063,000
35,765,000
31,320,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.